Insider filing · RPRX
George W. Lloyd
EVP, Investments & CLO
profile →
Royalty Pharma plc
RPRX · Healthcare · 36 filings in 24 months
ticker →
George W. Lloyd sold $5.1M of Royalty Pharma (RPRX)
Executed Nov 19 2025, disclosed Nov 21 2025, 2 days later.
Value, as filed
$5.1M
132,726 sh across 6 lots
Executed
Nov 19 2025
the trade date, as filed
Disclosed
Nov 21 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GLGeorge W. Lloyd (EVP, Investments & CLO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Royalty Pharma plc (RPRX). The largest single filing was $5.1M of RPRX (132,726 sh across 6 lots, as filed), executed Nov 19 2025.
The name
RPRXHealthcare · Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the U…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by George W. Lloyd in RPRX
RPRXSALE
Royalty Pharma plc
$4.2M110,000 sh across 2 lots
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET RPRXSALE Royalty Pharma plc $4.4M
110,000 sh × $39.77
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET